Hundreds of people with a form of the most common form of lung cancer could survive twice as long with the disease, thanks to a drug now available on the NHS. The drug, durvalumab, can double the overall time someone can survive with an aggressive form of lung cancer from two and a half to […]
Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.